These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6217968)

  • 1. Allergic reaction to DDAVP in diabetes insipidus: successful treatment with its graded doses.
    Yokota M; Matsukura S; Kaji H; Taminato T; Fujita T
    Endocrinol Jpn; 1982 Aug; 29(4):475-7. PubMed ID: 6217968
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of diabetes insipidus with DDAVP.
    Lampert RP; Blackett PR; Rennert OM
    J Pediatr; 1978 Nov; 93(5):896-7. PubMed ID: 712511
    [No Abstract]   [Full Text] [Related]  

  • 4. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
    Radó J; Pató E
    Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 6. DDAVP modified water-deprivation test in diagnosis of diabetes insipidus in a vasopressin-sensitive patient.
    Warner BA; Trautlein JJ; Caputo G; Manni A
    J Am Osteopath Assoc; 1984 Aug; 83(12):857-8. PubMed ID: 6237079
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of central diabetes insipidus with DDAVP.
    Chiu WT; Shih CJ; Chen HY; Lin LS
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):944-52. PubMed ID: 3865998
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of Schwartz-Bartter syndrome following administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin].
    Valkusz Z; Laczi F; László F
    Orv Hetil; 1981 Jan; 122(2):97-8. PubMed ID: 7231991
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP; Marosi J; Fischer J
    Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year experience with DDAVP in treatment of diabetes insipidus.
    Marek J; Loutocký A; Pacovský V; Zaoral M
    Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
    Kosman ME
    JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exogenous allergic alveolitis].
    Il'kovich MM; Borisenko LV; Vasil'chuk IV
    Probl Tuberk; 1983 Aug; (8):36-8. PubMed ID: 6634689
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
    Cunnah D; Ross G; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two new modes of desmopressin (DDAVP) administration.
    Grossman A; Fabbri A; Goldberg PL; Besser GM
    Br Med J; 1980 May; 280(6225):1215. PubMed ID: 7388473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.